Search Results - subject:"Diffuse large B-cell lymphoma"

Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL) : a discrete event simulation model on a UK population-based observational cohort

Wang, Han-I.; Smith, Alexandra; Aas, Eline; Roman, Eve; … - In: The European journal of health economics : HEPAC ; … 18 (2017) 2, pp. 255-267

Persistent link: https://www.econbiz.de/10011867795

Cost Effectiveness of Rituximab for Non-Hodgkin's Lymphoma: A Systematic Review

Auweiler, Philipp W.P.; Muller, Dirk Mller; Stock, Stephanie - In: PharmacoEconomics 30 (2012) 7, pp. 537-549

Background:Background: The monoclonal antibody rituximab has shown clinical effectiveness in combination with chemotherapy for the treatment of non-Hodgkin's lymphoma (NHL) in several randomized controlled studies. Rituximab maintenance therapy is associated with significant improvement in...

Persistent link: https://www.econbiz.de/10010551727

Cross-Validated Bagged Prediction of Survival

Sinisi, Sandra; Neugebauer, Romain; Laan, Mark van der - In: Statistical Applications in Genetics and Molecular Biology 5 (2009) 1, pp. 12-12

diffuse large B-cell lymphoma based on gene expression variables. …

Persistent link: https://www.econbiz.de/10005046589

Cross-Validated Bagged Prediction of Survival

Sinisi, Sandra; Neugebauer, Romain; Laan, Mark van der - In: Statistical Applications in Genetics and Molecular Biology 5 (2007) 1, pp. 12-12

diffuse large B-cell lymphoma based on gene expression variables. …

Persistent link: https://www.econbiz.de/10005246458